Sanofi (ENXTPA:SAN) Reports Positive Phase 3 Results for Itepekimab in COPD Trial
Sanofi announced that its AERIFY-1 trial with Regeneron Pharmaceuticals successfully met its primary endpoint, indicating progress in COPD treatment. Despite this positive news, the company's share price fell 5% over the last week, contrasting with a 2% rise in the broader market. This decline may reflect investors' reactions to other company initiatives, such as its partnership with Stagecoach Performing Arts to raise awareness of autoimmune Type 1 diabetes. These positive developments, although promising, were not enough to counterbalance the broader market's upward trend, contributing weight against Sanofi's price movement.
Buy, Hold or Sell Sanofi? View our complete analysis and fair value estimate and you decide.
Uncover the next big thing with financially sound penny stocks that balance risk and reward.
The recent successful completion of Sanofi's AERIFY-1 trial could have a positive impact on its revenue and earnings forecasts by strengthening its position in the COPD treatment market. However, despite these promising developments, the company's share price experienced a 5% decline in the past week, contrasting with the broader market's 2% rise. This movement might reflect investor reactions to other company initiatives, such as the partnership with Stagecoach Performing Arts, and broader market trends.
Looking at a longer-term context, Sanofi's shares have delivered a total return of 19.59% over the past five years. Recent performance has exceeded the French Pharmaceuticals industry and market, which returned 4% and 4.5% declines respectively over the last year. Such outperformance indicates resilience amidst industry challenges and market volatility.
Please consider the current share price of €95.9 against the consensus price target of €117.17, indicating a potential upside potential of approximately 18.5%. This price target is based on expectations of revenue reaching €51.2 billion and earnings of €10.2 billion by 2028, trading on a PE ratio of 16.1x. Analysts are assuming that Sanofi will enhance its growth trajectory driven by its innovative treatments and efficient operational strategies.
Assess Sanofi's previous results with our detailed historical performance reports.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ENXTPA:SAN.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Marshall Monteagle Full Year 2025 Earnings: EPS: US$0.017 (vs US$0.10 in FY 2024)
Revenue: US$85.2m (up 2.6% from FY 2024). Net income: US$615.0k (down 83% from FY 2024). Profit margin: 0.7% (down from 4.4% in FY 2024). The decrease in margin was driven by higher expenses. EPS: US$0.017 (down from US$0.10 in FY 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Marshall Monteagle's share price is broadly unchanged from a week ago. Before we wrap up, we've discovered 2 warning signs for Marshall Monteagle that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
CNBC
36 minutes ago
- CNBC
France is betting Eutelsat can become Europe's answer to Starlink — but experts aren't convinced
For years, France's Eutelsat has been trying to build a European alternative to Elon Musk's Starlink satellite broadband service. The company merged with British satellite venture OneWeb in 2023, consolidating the region's satellite communications industry in an effort to catch up to Starlink, which is owned by SpaceX. Last week, the French state led a 1.35-billion-euro ($1.58 billion) investment in Eutelsat, making it the company's biggest shareholder with a roughly 30% stake. Europe largely lags behind the U.S. in the global space race. Starlink's constellation of over 7,000 satellites dwarfs Eutelsat's. Meanwhile, Europe's launch capabilities are more limited than the U.S. The region still relies heavily on America for certain launch services, which is a market dominated by SpaceX. Eutelsat currently has a market capitalization of 1.6 billion euros, much lower than estimates for Starlink owner SpaceX's value, which was pegged at $350 billion in a secondary share sale last year. In 2020, analysts at Morgan Stanley said that they see Starlink growing to $80.9 billion in their "base case valuation" for the firm. Luke Kehoe, industry analyst at network monitoring firm Ookla, said France's investment in Eutelsat shows the country "is now treating Eutelsat less like a commercial telco and more like a dual-use critical-infrastructure provider" and a "strategic asset" in the European Union's push for technological sovereignty. However, building a European competitor to Starlink will be no mean feat. Communications industry experts tell CNBC that, while Eutelsat could boost Europe's efforts to create a sovereign satellite internet provider, challenging its U.S. rival Starlink would require a significant increase in investments in Low Earth Orbit (LEO) satellites. Eutelsat's OneWeb arm operates a total of 650 LEO satellites, which is less than a tenth of Starlink's 7,600-strong global satellite constellation. "To offer greater capacity and coverage, [Eutelsat] needs to increase the number of satellites in space, a task made more difficult due to the fact that many of OneWeb's satellites are nearing the end of their lifespan and will need to be first replaced before growing the constellation's size," Joe Gardiner, research analyst at market research firm CCS Insight, told CNBC via email. Ookla's Kehoe echoed this view. "Eutelsat's chances of achieving parity with Starlink in the mass-market satellite broadband segment within the next five years remain limited, given SpaceX's unmatched global scale in LEO infrastructure," he said. "Even with the latest injection of capital from the French state, Eutelsat continues to lag behind Starlink in several key areas, including capital, manufacturing throughput, launch access, spectrum and user terminals." Nevertheless, he thinks the company is "well positioned to succeed in European-sovereign, security-sensitive and enterprise segments that prioritise jurisdictional control and sovereignty over raw constellation capacity." The enterprise segment refers to the market for corporate space clients. That's certainly the hope. France's Emmanuel Macron has urged Europe to ramp up its investment in space, saying last week that "space has in some way become a gauge of international power." When Eutelsat announced its investment from France last week, the firm stressed its role as "the only European operator with a fully operational LEO network" as well as the "strategic role of the LEO constellation in France's model for sovereign defense and space communications." Earlier this year, Eutelsat was rumoured to be in the running to replace Starlink in Ukraine. For years, Starlink has offered Ukraine's military its satellite internet services to assist with the war effort amid Russia's ongoing between the U.S. and Ukraine soured following the election of President Donald Trump and reports surfaced that U.S. negotiators had raised the possibility of cutting Ukraine's access to Starlink. Germany set up 1,000 Eutelsat terminals in Ukraine in April with the aim of providing an alternative — rather than a replacement — for Starlink's 50,000 terminals in the war-torn country. Since then, U.S.-Ukraine tensions have somewhat cooled, and Starlink remains the primary satellite broadband provider to the Ukrainian military. Eutelsat's former CEO Eva Berneke has herself admitted that the company cannot yet match Starlink's scale. "If we were to take over the entire connectivity capacity for Ukraine and all the citizens — we wouldn't be able to do that. Let's just be very honest," she said in an April interview with Politico. Berneke was replaced as CEO in May by Jean-Francois-Fallacher, a former executive of French telecoms giant Orange. Meanwhile, even though Eutelsat has been ramping up investments in LEO satellite with its OneWeb unit, experts say its technical architectures and orbital designs are ultimately different from Starlink's. "The OneWeb constellation currently uses a bent-pipe architecture, which is not as capable as Starlink satellites; therefore, OneWeb will also need to invest in second-generation satellites," he added. The French firm's use cases also differ to Starlink's. Eutelsat operates a constellation of geostationary orbit (GEO) as well as LEO satellites. GEO satellites orbit the earth at a much higher altitude than their LEO equivalents and can typically cover more land with fewer satellites. "Eutelsat's higher altitude satellites are leveraged for specialized use cases, such as polar coverage for companies and research facilities in remote regions like Greenland and Alaska," said Joe Vaccaro, vice president and general manager at Cisco's ThousandEyes network intelligence unit. Looking ahead, Eutelsat said it plans to "build upon its operation improvements" with a "differentiated go-to-market model" and "strong European anchoring." It also noted that the U.K. government could also increase its investment in Eutelsat "in due course."
CNBC
37 minutes ago
- CNBC
The global week ahead: A hectic half first heralds a volatile second
"Politics isn't wagging the tail – it's shaking the entire dog." These strong words from one wealth manager to CNBC last week capture a hectic first half of trading. They also set the stage for an uncertain second half, where "geoeconomics" looks set to remain a dominant market force. This week, expect attention to return to monetary policy, as central bankers from across the globe — who have kept their heads down amid political tensions — prepare to speak at the ECB Forum in Sintra, Portugal. A lot has happened in the last six months, with trade tensions and truces sending equity markets across the globe haywire. The VIX volatility index — also known as the Wall Street fear gauge — spiked in April as tariff threats, followed by tariff pauses, caused huge intraday swings across major indices. Meanwhile, "black swan" moments in the Middle East also kept investors on edge. Amid all the uncertainty, some stock markets showed remarkable resilience: Germany's Dax remains the outperformer in Europe, up over 18% so far this year, followed by London's FTSE 100 up around 9%, while the French CAC 40 lags with around 5% gains. But what does this all mean for trading in the second half of the year? Goldman Sachs warns that, "elevated policy uncertainty paired with a worsening macro backdrop are likely to support higher equity volatility in the next months."As Goldman's warning rings loudly in investors' ears, the stage is set for central banks to return to the limelight. This week, the town of Sintra in Portugal plays host to the annual ECB Forum, where European central bankers are joined by their international counterparts to exchange views on current policy issues. The sun may well be shining in Portugal — but President Donald Trump's recent comments will no doubt cast a shadow over the meeting, as he continues to put unprecedented pressure on Federal Reserve Chair Jerome Powell. Just last week, Trump's name-calling of Powell ramped up, sparking talk of a so-called "shadow Fed chair," who could keep an eye on things until taking over as chair next year. Powell also put the pressure on his monetary policy peers, calling on central bankers to hold steady until they see the impact of trade tariffs: "We are well positioned to wait and learn more about the likely course of the economy before considering any adjustments to our policy stance." Europe will need to decide how much it lets the U.S. approach dictate its policy, with ECB President Christine Lagarde opening proceedings in Sintra with a speech on Monday evening. Expect a punchy tone; her recent op-ed in the Financial Times saw her call for the euro to take advantage of the current environment and "gain global prominence." Next Friday marks the first anniversary of the Labour Party taking power in the U.K., following 14 years of Conservative rule. A landslide victory saw a jubilant Labour return to Downing Street with the promise of change and growth. But the honeymoon period was short-lived. Fast-forward 12 months and Prime Minister Keir Starmer looks set to reach his first year in office with plummeting approval ratings which put him below his rival party leaders, including Reform's Nigel Farage, Liberal Democrat Sir Ed Davey and Conservative leader Kemi Badenoch. Starmer has faced a lot of external pressure, ranging from a public spat with Elon Musk to a slew of foreign policy challenges in Ukraine and the Middle East. Even three trade deals — with Europe, India and the very first U.S. agreement — did little to improve his popularity. But the economic challenges at home are causing the most discontent, with pressure even from within his own party to review certain reforms.
